Opperman Sarah R

Director Opperman bought 277 ISBA shares at $49.58; 6 other insiders also bought within 14 days. Stock at $50.70, -10.4% from 52-week high.

Director Sarah R Opperman purchased 277 shares at $49.58 on 2026-01-20, adding 1.1% to her holdings of 24,412 shares. This buy occurs within a 14-day cluster in which 6 other insiders also bought, suggesting coordinated confidence rather than an isolated transaction. Opperman's prior buys at ISBA show mixed timing outcomes: 3 of 5 prior trades were well-timed at the 90-day mark, with her most recent ISBA purchase (2025-01-24) showing a 30-day return of -3.1% and a 90-day return of +0.1%. The current stock price of $50.70 is -10.4% from its 52-week high of $56.58, positioning the purchase in a region where the stock has declined 30 days but recovered 41.3% over 90 days. Fundamental metrics show the company is profitable (net income $5.2M, P/E 20.44, market cap $371.9M) with modest annual revenue growth of 5.0%. The multi-insider buy cluster and the company's stable financial position warrant attention, though Opperman's historical accuracy at ISBA remains moderately predictive rather than definitive.

ISBA Director Opperman bought 532 shares at $25.80 (cluster pattern: 5 other insiders in 14 days)

Director Sarah R Opperman purchased 532 shares of ISABELLA BANK Corp at $25.80 on 2025-01-24, increasing her holdings by 2.3% to 23,785 shares. This purchase is part of a broader cluster: 5 other insiders also bought within the past 14 days, suggesting coordinated or independently motivated accumulation at current levels. At the company level, recent financials show net income of $3,281,000.00 against quarterly revenue of $1,439,000.00, with a P/E of 14.02 and a market cap of $191,758,914.42. Opperman's own track record at ISBA shows mixed timing: 2 of 5 prior buys resulted in positive 90-day returns, while recent purchases in early 2024 were followed by declines (-4.5% and -9.7% in the 30-day window). The current price of $25.79 is 0.8% below the 52-week high and flat over the past 30 days, but the stock has gained 19.1% over 90 days, setting a different backdrop than her January 2024 purchase at similar price levels.